Medication review before an oral GLP-1 switch

Switching to a daily tablet is a medication change, even when the new prescription contains the same ingredient as the old one. The useful preparation is a clear history and a product-specific plan from the prescribing team. A dose conversion found online cannot account for the formulation, reason for treatment, interruption history or other medicines in the clinical decision.

Write down what is actually being replaced

Bring the old package or a clear medication record. Include the exact name, route, strength, current directions and date of the last administration. Record any gap in treatment and the reason for considering a switch. “I used semaglutide” leaves too much unresolved when several oral and injectable formulations exist.

The current Rybelsus/Ozempic tablet label explicitly says those tablet products are not substitutable on a milligram-for-milligram basis and provides defined switching instructions. This is a concrete reason to avoid matching numbers across packages. A larger printed number is not a universal measure of greater treatment intensity across formulations or routes. Have the prescriber identify the appropriate pathway rather than calculating one yourself.

Interaction review is broader than pill timing

A pharmacokinetic interaction study in healthy volunteers found increased total thyroxine exposure when a studied oral semaglutide regimen was coadministered with levothyroxine. It also investigated coadministered tablets. This is a specific experimental finding, not proof that all combinations behave similarly or that a person should change thyroid medicine independently. It illustrates why a complete medication list matters.

For orforglipron, use Foundayo’s own interaction and contraception instructions. The label includes medication interactions and advises additional or nonoral contraception for a defined period after initiation and dose escalation. Those instructions should not be transferred automatically to a semaglutide product. The pharmacist or prescriber can explain which product-specific precautions apply to the proposed change.

A medication list that can actually be reviewed

• Prescription names, strengths, routes and the times they are taken.
• Nonprescription medicines, vitamins, supplements and intermittent treatments.
• Medicines with empty-stomach requirements or monitoring appointments.
• Contraception, pregnancy plans and relevant upcoming procedures.
• Prior adverse effects, recent vomiting or difficulty maintaining the current routine.

Include the purpose of each medicine when you know it, but leave uncertain entries marked for clarification. Avoid removing an item because it seems unrelated to weight or diabetes. A professional review works best from the full list, including medicines prescribed by other clinicians. Update the record when a prescription changes rather than maintaining conflicting versions.

Ask for a written handoff

The plan should name the old and new medicines, state who is coordinating the change, and explain what to do about a gap, a missed dose or an unexpected reaction. Ask which measurements or follow-up contacts are needed and when the first review will occur. If the pharmacy label differs from the plan, ask the clinical team to reconcile them before interpreting the difference yourself.

Keep administration instructions separate from interaction instructions: following a food rule does not automatically resolve every drug interaction. Likewise, spacing two tablets does not establish that a combination is appropriate. The final plan should be understandable enough to follow without relying on a social-media conversion chart. Your role is to bring accurate information and surface practical conflicts; the prescribing team determines the treatment change.